Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytochrome P450 3A: genetic polymorphisms and inter-ethnic differences.

D R Krishna1, M S Shekar

  • 1Drug Metabolism, Cancer and Aging Research Lab, Department of Pharmacology, University College of Pharmaceutical Sciences, Kakatiya University, Warangal, Andhra Pradesh, India. dr_krishna@rediffmail.com

Methods and Findings in Experimental and Clinical Pharmacology
|November 8, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of unrefined sorghum or maize on serum lipids.

Ancient science of life·2012
Same author

Influence of diosmin pretreatment on the pharmacokinetics of chlorzoxazone in healthy male volunteers.

Drug metabolism and drug interactions·2009
Same author

Study of insulin resistance in relation to serum IGF-I levels in treated type-II diabetic patients.

The Journal of the Association of Physicians of India·2008
Same author

HIV sero-prevalance in general population of Warangal, A.P., South India.

Journal of environmental biology·2008
Same author

Probenecid affects the pharmacokinetics of ofloxacin in healthy volunteers.

Clinical drug investigation·2008
Same author

Oxidative stress and anti-oxidant status in leprosy patients.

Indian journal of leprosy·2004
Same journal

[Proceedings of the XVIII TASPE Seminar, Granada, Spain, 4-5 February 2010].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Treatment algorithm for gastrointestinal graft-versus-host disease].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Treatment of chronic graft-versus-host disease with protein tyrosine kinase inhibitors].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Classification of chronic graft-versus-host disease].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Pegfilgrastim in hematopoietic stem cell transplantation].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Allogeneic transplantation in multiple myeloma patients: results and recommendations in February 2010].

Methods and findings in experimental and clinical pharmacology·2011
See all related articles

Genetic variations in drug metabolism enzymes, particularly cytochrome P450 (CYP3A), differ between ethnic populations. This review explores ethnic variations and genetic polymorphism in CYP3A-mediated drug metabolism.

Area of Science:

  • Pharmacogenomics
  • Drug Metabolism
  • Biochemistry

Background:

  • Ethnicity influences drug response due to genetic variations in drug-metabolizing enzymes.
  • Cytochrome P450 enzymes, especially CYP3A, are crucial for metabolizing a large proportion of prescribed drugs.
  • Inter-ethnic differences in CYP3A activity and metabolism are well-documented.

Purpose of the Study:

  • To review genetic polymorphism and ethnic variations in CYP3A-mediated oxidative drug metabolism.
  • To highlight the impact of ethnicity on drug metabolism and response.

Main Methods:

  • Literature review focusing on genetic polymorphism.
  • Analysis of studies reporting ethnic variations in CYP3A activity.
  • Examination of CYP3A-mediated drug metabolism pathways.

Related Experiment Videos

Main Results:

  • Frequencies of genetic polymorphisms in drug-metabolizing enzymes vary significantly across different populations.
  • Distinct CYP3A variants are observed in different ethnic groups, affecting enzyme activity.
  • Inter-ethnic variability in CYP3A-mediated drug metabolism contributes to differences in drug response.

Conclusions:

  • Genetic polymorphism and ethnic variations in CYP3A are key factors in interindividual differences in drug metabolism.
  • Understanding these variations is essential for personalized medicine and optimizing drug therapy across diverse populations.